Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Argos Therapeutics Presents New Phase 2 Data Showing its Arcelis ... - PR Newswire (press release) |
 |
 |
|
PR Newswire (press release) DURHAM, NC, June 5, 2011 /PRNewswire/ -- Argos Therapeutics today announced that new data from its Phase 2 combination study of its Arcelis™ immunotherapy for the treatment of renal cell carcinoma (RCC), AGS-003, in combination with sunitinib showed |
